Categories
-
Adhesives
5
Amines
91
Amino Acids
179
Analytical Reagents
668
Antibiotics
246
Bioactive Small Molecules
715
Aroma Chemicals
203
Biochemicals
1003
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
6
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
89
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
752
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
80
Water Analysis
12
Rapamycin
(41676136 | 53123-88-9)
CAS: | 53123-88-9 |
---|---|
Molecular Formula: | C51H79NO13 |
Molecular Weight: | 914.17 |
Availablility: | In Stock |
---|---|
Downloads: | | |
41676136-100mg | 100mg | £83.80 | |
Bulk Order |
41676136-100mg | 100mg | €117.40 | |
Bulk Order |
41676136-100mg | 100mg | $125.70 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 41676136 | ||||
Product Name | Rapamycin | ||||
Categories | Biochemicals Organics Research Organics & Inorganics | ||||
CAS | 53123-88-9 | ||||
Molecular Formula | C51H79NO13 | ||||
Molecular Weight | 914.17 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 2934999090 |
Product Specification
Water | ≤ 1.0% | ||||
Purity (HPLC) | ≥ 98.5% (dried basis) | ||||
Heavy metals | ≤ 20ppm | ||||
Assay | 98.0 - 102.0% | ||||
Optical Rotation | -147 to -157° | ||||
Residue on Ignition | ≤ 0.15% | ||||
Appearance | White to Off-white powder | ||||
Identification (IR) | Conforms to Reference | ||||
Identification (HPLC) . | Conforms to Reference |
Safety Information
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|